| Astghik Harootunian, LCSW | |
|
141 S Cedar St, Glendale, CA 91205-1207 | |
| (818) 839-4010 | |
| (818) 839-4011 |
| Full Name | Astghik Harootunian |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 141 S Cedar St, Glendale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154059020 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 985809 (California) | Secondary |
| 1041C0700X | Social Worker - Clinical | 98582 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Astghik Harootunian, LCSW 519 E Broadway, Glendale, CA 91205-1110 Ph: (818) 409-3020 | Astghik Harootunian, LCSW 141 S Cedar St, Glendale, CA 91205-1207 Ph: (818) 839-4010 |
News Archive
The College of American Pathologists (CAP) and the American Society for Colposcopy and Cervical Pathology (ASCCP) jointly issued The Lower Anogenital Squamous Terminology (LAST) Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations.
In a study of more than 8,000 adults, those with a chronic health condition such as diabetes or asthma were more likely to report psychological distress and functional impairment if they were residents of poor or middle-income households.
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.
Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.
› Verified 1 days ago
Natalie Anne Innocenzi, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1118 Newby St, Glendale, CA 91201 Phone: 626-818-0077 | |
Mary Ann Dunham, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 444 W Glenoaks Blvd, Glendale, CA 91202 Phone: 818-552-3000 | |
Francie Issenman, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 320 Arden Ave, Suite 240, Glendale, CA 91203 Phone: 818-759-3433 | |
Stella Luna Petros, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 237 N Central Ave, C, Glendale, CA 91203 Phone: 818-547-9544 | |
Elizabeth Pashanian, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 138 N Brand Blvd Ste 200, Glendale, CA 91203 Phone: 424-413-0949 | |
Knar Kaakejian, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1137 N Central Ave, Glendale, CA 91202 Phone: 818-456-8674 |